Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Argues Its Strategy Is Delivering As It Makes More Cuts, Including In R&D

Feb 08 2010

• By The Pink Sheet

Related Content

GlaxoSmithKline Buys Back Into Dermatology With $2.9 Billion Stiefel Deal

Apr 20 2009

GSK Tries to Mimic Real-World Biotech

Feb 01 2009

GSK’s Vallance Teams Up With Ex-University London Colleagues In Pentraxin Deal

Mar 25 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window